Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Acquired Immune Deficiency Syndrome

arginyl-glycyl-aspartic acid has been researched along with Acquired Immune Deficiency Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barillari, G; Ensoli, B; Gallo, RC; Gendelman, R1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Acquired Immune Deficiency Syndrome

ArticleYear
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Sep-01, Volume: 90, Issue:17

    Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Antibodies; Cell Adhesion; Cells, Cultured; Culture Media, Conditioned; Endothelium, Vascular; Gene Products, tat; HIV-1; Humans; Integrins; Lymphocyte Activation; Molecular Sequence Data; Muscle, Smooth, Vascular; Oligopeptides; Peptide Fragments; Receptors, Cytoadhesin; Receptors, Fibronectin; Receptors, Vitronectin; Recombinant Proteins; Sarcoma, Kaposi; T-Lymphocytes; tat Gene Products, Human Immunodeficiency Virus

1993